Day: February 19, 2025

Form 8.3 – [ALLIANCE PHARMA PLC – 18 02 2025] – (CGWL)

Written by Customer Service on February 19, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree ALLIANCE PHARMA PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Progressive Reports January 2025 Results

Written by Customer Service on February 19, 2025. Posted in Earnings Releases And Operating Results.

MAYFIELD VILLAGE, OHIO, Feb. 19, 2025 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE:PGR) today reported the following results for the month ended January 31, 2025: January(millions, except per share amounts and ratios; unaudited) 2025 2024 ChangeNet premiums written $ 6,481 $ 5,496 18 %Net premiums earned $ 6,586 $ 5,386 22 %Net income $ 1,117 $ 701 59 %Per share available to common shareholders $ 1.90 $ 1.18 61 %Total pretax net realized gains (losses) on securities $ 109 $ 17 NM Combined ratio 84.1 87.3 (3.2 ) pts.Average diluted equivalent common shares 587.7 587.3 0 %NM = Not Meaningful January 31,(thousands; unaudited) 2025 2024 % ChangePolicies in Force Personal Lines Agency...

Form 8.3 – [LEARNING TECHNOLOGIES GROUP PLC – 18 02 2025] – (CGWL)

Written by Customer Service on February 19, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree LEARNING TECHNOLOGIES GROUP PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date...

Abacus Life Completes the Rebranding of FCF Advisors with New ETF and Fee Reductions

Written by Customer Service on February 19, 2025. Posted in Public Companies.

ORLANDO, Fla., Feb. 19, 2025 (GLOBE NEWSWIRE) — Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering global alternative asset manager specializing in leveraging longevity data and actuarial technology to offer uncorrelated investment opportunities, today announces the rebranding of FCF Advisors to Abacus FCF Advisors, a subsidiary of ABL Wealth. This rebrand highlights the manager’s position as a leader in free cash flow investing and analytics by pioneering the FCF Leaders Model, which serves as the foundation for the firm’s quantitative investment process that identifies the most profitable companies. As part of the rebrand, Abacus FCF Advisors announced the launch of the Abacus FCF Small Cap Leaders ETF (ticker: ABLS), and management fee reductions of 5-10 basis points across all ETFs. An 18-month fee waiver...

iCAD To Showcase Five AI-Powered Research Presentations Advancing Breast Cancer Detection, Risk Evaluation, and Breast Arterial Calcification Assessment at ECR 2025

Written by Customer Service on February 19, 2025. Posted in Public Companies.

NASHUA, N.H., Feb. 19, 2025 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today announced that five clinical presentations and abstracts highlighting the Company’s advancements in breast cancer detection, risk evaluation, and breast arterial calcification (BAC) assessment have been accepted for presentation at the European Congress of Radiology (ECR) 2025, which will take place from February 26 to March 2, 2025, in Vienna, Austria. Led by research collaborators, these studies underscore iCAD’s commitment to delivering artificial intelligence (AI) powered solutions to advance personalized risk assessment, enhance early detection, and optimize breast...

NKGen Appoints Dr. Anita Fletcher as National Principal Investigator for Phase 2a Troculeucel Trial Evaluating Moderate Alzheimer’s Disease with AdventHealth Orlando as First East Coast Site

Written by Customer Service on February 19, 2025. Posted in Public Companies.

SANTA ANA, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) — NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell therapeutics, today announced that Anita Fletcher, M.D. has been appointed as the National Principal Investigator (“PI”) for its Phase 2a clinical trial of troculeucel, expanded enhanced autologous NK cell therapy, for the treatment of moderate Alzheimer’s disease (NCT06189963). In addition to Dr. Fletcher’s appointment as National PI, NKGen is pleased to announce AdventHealth Research Institute, Neuroscience Research in Orlando will be the first clinical site on the East Coast with the intent of enrolling moderate stage Alzheimer’s Disease (AD) patients in the very...

News from North Macedonia: First Division Clubs Brera Strumica and Brera Tiverija Strengthen Their Squads for the Spring Championship Following the Men’s and Women’s Winter 2024-25 Transfer Window

Written by Customer Service on February 19, 2025. Posted in Public Companies.

The Brera Strumica team against Pelister in the Macedonian First Football League, on February 16, 2025The Brera Strumica team against Pelister in the Macedonian First Football League, on February 16, 2025The Brera Strumica team against Pelister in the Macedonian First Football League, on February 16, 2025 Dublin, Ireland and Strumica, North Macedonia, Feb. 19, 2025 (GLOBE NEWSWIRE) — Following the winter 2024-25 transfer window, Brera Holdings PLC’s (Nasdaq: BREA) portfolio clubs in North Macedonia, Brera Strumica and Brera Tiverija, are pleased to announce several exciting signings that they believe will strengthen their squads ahead of the spring championship. These additions reflect the clubs’ ongoing commitment to player development and the expansion of their talent pathways, particularly from Africa and Eastern...

LGI Homes Opens New Section at Homestead Estates in Elgin, Texas

Written by Customer Service on February 19, 2025. Posted in Public Companies.

The Torres Plan by LGI Homes at Homestead EstatesThe Torres Plan by LGI Homes at Homestead Estates features five bedrooms, three-and-a-half bathrooms, and a spacious family room.AUSTIN, Texas, Feb. 19, 2025 (GLOBE NEWSWIRE) — LGI Homes is excited to announce the grand opening of a new section at Homestead Estates, an incredible community located in Elgin, Texas. This new section offers an array of beautifully designed, affordable and upgraded homes, giving homebuyers the opportunity to own a brand-new home in a highly desirable location starting in the $290s. Homestead Estates offers a variety of brand-new one- and two-story homes, perfect for families and individuals seeking exceptional value in a vibrant community. The homes in this new section include brand-new floor plans with three to five bedrooms and feature spacious,...

VYNE Therapeutics Initiates Phase 1b Trial of VYN202, a Novel BD2-Selective Oral BET Inhibitor, in Plaque Psoriasis

Written by Customer Service on February 19, 2025. Posted in Public Companies.

Oral, once-daily doses of VYN202 being evaluated in subjects with moderate-to-severe plaque psoriasisTop-line data from the 12-week double-blind trial expected by year-end 2025Phase 1b trial designed to provide key insights into VYN202’s potential across a range of chronic, immune-mediated diseasesBRIDGEWATER, N.J., Feb. 19, 2025 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune-mediated conditions with high unmet need, today announced that the first subject has been dosed in a Phase 1b trial evaluating VYN202 in moderate-to-severe plaque psoriasis. VYN202 is an oral small molecule BD2-selective bromodomain and extra-terminal domain (BET) inhibitor that is...

FOREWARN to Provide Identity Verification Services to Denver Metro Association of REALTORS® to Promote Agent Safety

Written by Customer Service on February 19, 2025. Posted in Public Companies.

The largest local REALTOR® Association in the state of Colorado contracts to make FOREWARN services available for its 7,000+ real estate professional members to promote proactive agent safety BOCA RATON, Fla. , Feb. 19, 2025 (GLOBE NEWSWIRE) — FOREWARN, LLC, a red violet company (NASDAQ: RDVT) and the leading provider of real-time information solutions for real estate agents, today announced that Denver Metro Association of REALTORS® (“DMAR”) will offer FOREWARN® services to its 7,000+ members it serves throughout the Denver metropolitan area to promote proactive real estate agent safety. Available both online and through a mobile application, FOREWARN analyzes billions of data points and provides users with the ability to mitigate risks by verifying identity, searching for criminal histories, and validating information provided...

Day: February 19, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals